Meet the MiyaHealth Team
Dr. Ramesh Rajentheran
Chief Executive Officer & Co-Founder
Ramesh is CEO and a co-founder. He has spent over 2 decades in healthcare as a doctor, a healthcare investment banker, a senior healthcare executive and now as a healthtech co-founder. He was the former CFO and COO at Fullerton Health in Singapore where he helped run Asia’s largest managed care business. He was also the Managing Director and Head of Asian Healthcare Investment Banking at Barclays in Hong Kong/Singapore, an Executive Director at Morgan Stanley & UBS in London, and has executed numerous healthcare deals around the world. During his time as a physician in the NHS in the UK, he published research on oncology in several European publications. He also served as Head of Markets and advisor to the Chairman of Hong Leong Group in Malaysia.
When he isn’t trying to see around corners on behalf of MiyaHealth- he enjoys 20-minute workouts and fantasizing about being an architect by designing his own Lego architecture models. Ramesh has a MBA from London Business School and qualified as a doctor in Newcastle where he was a Commonwealth/Chevening Scholar. He is also on the boards of several private and public companies, as well as on the board of It's Raining Raincoats, a non-profit in Singapore.
When he isn’t trying to see around corners on behalf of MiyaHealth- he enjoys 20-minute workouts and fantasizing about being an architect by designing his own Lego architecture models. Ramesh has a MBA from London Business School and qualified as a doctor in Newcastle where he was a Commonwealth/Chevening Scholar. He is also on the boards of several private and public companies, as well as on the board of It's Raining Raincoats, a non-profit in Singapore.
Bevan Cheong
Chief Product Officer & Co-Founder
Bevan oversees our product and is a co-founder. An actuary and health technologist who had founding roles in Accident & Health businesses, Bevan was the former CTO at Tokio Marine Life Insurance Singapore where he launched fund execution and information platforms and overhauled customer portals for a more intuitive experience. He was also Vice President of Manulife Singapore, where he helped found the Accident and Health business . He also Co-Chaired the Digital Subcommittee of the Life Insurance Association of Singapore.
Bevan is passionate about learning and education and is currently an Associate of the Society of Actuaries (USA). Previously, he was a Healthcare Technology Researcher at Kinetic Consulting London. He also taught the actuarial science programme as an Adjunct Professor at The Cass Business School of City University, London.
When he isn’t creating our next big product– Bevan “runs for fun”. Bevan has a MSc in Health Informatics from City University and a Bbus in Actuarial Science at Nanyang Technological University.
Bevan is passionate about learning and education and is currently an Associate of the Society of Actuaries (USA). Previously, he was a Healthcare Technology Researcher at Kinetic Consulting London. He also taught the actuarial science programme as an Adjunct Professor at The Cass Business School of City University, London.
When he isn’t creating our next big product– Bevan “runs for fun”. Bevan has a MSc in Health Informatics from City University and a Bbus in Actuarial Science at Nanyang Technological University.
Shirley Ah Hee
Chief Operating Officer & Co-Founder
Shirley oversees our Operations, Finance, Legal and HR and is a co-founder. Shirley has 20 years of experience in leading innovative initiatives spanning front to back processes, data management, technology transformation, mergers & acquisitions, risk and treasury. She has held multiple advisory and management roles in international companies within the United Kingdom, Mauritius and Singapore, giving her a global perspective.
Shirley has led finance transformations at Yifan Pharmaceutical, the Stamford International School and Fullerton Health. She also had various operational and advisory roles at the Royal Bank of Scotland in Singapore, Standard Bank Group in Mauritius, and Deloitte in London.
When she isn’t making our company tick, Shirley likes being outdoors, cycling the Park Connectors and making poor attempts at learning both the piano and Chinese, not necessarily at the same time. Shirley holds an MSc and Bsc in Econometrics and Mathematical Economics from the London School of Economics and Political Science, and is a Fellow Chartered Accountant from the Institute of Chartered Accountants in England and Wales. She has an ACI Dealing Certificate from the ACI Financial Markets Association and a Certificate in Treasury from the Association of Corporate Treasurers.
Shirley has led finance transformations at Yifan Pharmaceutical, the Stamford International School and Fullerton Health. She also had various operational and advisory roles at the Royal Bank of Scotland in Singapore, Standard Bank Group in Mauritius, and Deloitte in London.
When she isn’t making our company tick, Shirley likes being outdoors, cycling the Park Connectors and making poor attempts at learning both the piano and Chinese, not necessarily at the same time. Shirley holds an MSc and Bsc in Econometrics and Mathematical Economics from the London School of Economics and Political Science, and is a Fellow Chartered Accountant from the Institute of Chartered Accountants in England and Wales. She has an ACI Dealing Certificate from the ACI Financial Markets Association and a Certificate in Treasury from the Association of Corporate Treasurers.
Board of Directors
Aditya Mathur
Aditya is the founder and MD of Elev8.vc, a Deep Tech Venture Capital fund based in Singapore. Prior to elev8, Aditya operationally helped grow two multi billion-dollar Tech companies, which were both later acquired. Aditya follows his passion and supports founders in the B2B Deep Tech space to realize explosive sales growth. In his prior life, Aditya has led both software and hardware enterprise Tech sales into some of the biggest enterprises globally, across various industry verticals. Aditya has a B.Sc. in Engineering from Stanford University.
Jeremy Lim
Jeremy is director for global health in the Saw Swee Hock School of Public Health, National University of Singapore and leads the initiatives in health systems strengthening and universal health coverage. He brings diverse and unique perspectives having spent substantial time in public and private healthcare across Asia as well as in policy advisory with Singapore's Ministry of Health, the World Bank and the World Health Organization. Outside academia, Jeremy is CEO of AMILI, the region’s first precision microbiome company. He also serves as advisor or sits on the boards of various for-profit and not-for-profit organizations in different aspects of healthcare including healthcare financing, migrant worker health, end of life care and digital health interventions. He trained in surgery and public health, attaining post-graduate qualifications in both from the UK and US.
Geoffrey Ng
Geoffrey Ng is Managing Director with a leading regional financial institution. He has over two decades of investment management and leadership experience, having previously been attached with Fortress Capital Asset Management (Director), Hong Leong Asset Management (Executive Director/CEO), Dubai Investment Group (Senior Vice President, global emerging markets) and Pacific Mutual Fund (Chief Investment Officer. Geoffrey is a member of the CFA Institute’s board of governors, where he chairs the audit and finance, and nominating committees.
Dr. Ramesh Rajentheran
Ramesh is CEO and a co-founder. He has spent over 2 decades in healthcare as a doctor, a healthcare investment banker, a senior healthcare executive and now as a healthtech co-founder. He was the former CFO and COO at Fullerton Health in Singapore where he helped run Asia’s largest managed care business. He was also the Managing Director and Head of Asian Healthcare Investment Banking at Barclays in Hong Kong/Singapore, an Executive Director at Morgan Stanley & UBS in London, and has executed numerous healthcare deals around the world. During his time as a physician in the NHS in the UK, he published research on oncology in several European publications. He also served as Head of Markets and advisor to the Chairman of Hong Leong Group in Malaysia.